Clinical Trials Browser

INDUSTRY × Leukemia × Idarubicin × Clear all

NCT06578247 2026-02-27

QuANTUM-WILD

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT06001788 2025-12-03

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02668653 2024-08-06

QuANTUM-First

Phase 3 Completed

539 enrolled 20 charts 1 FDA

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute